UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C.  20549

FORM 10-Q

(Mark One)

[X] Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

For the period ended March 28,June 27, 2020

or

[ ] Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

For the transition period from          to

 

Commission file number          0-16088

 

CPS TECHNOLOGIES CORP.CORPORATION

(Exact Name of Registrant as Specified in its Charter)

 

 

Delaware

(State or Other Jurisdiction


of Incorporation or Organization)

04-2832509

(I.R.S. Employer


Identification No.)

 

111 South Worcester Street


Norton MA


(Address of principal executive offices)

 

02766-2102

(Zip Code)

 

(508) 222-0614

Registrant’s Telephone Number, including Area Code:

 

CPS TECHNOLOGIES CORP.Technologies Corporation

111 South Worcester Street

Norton, MA 02766-2102

Former Name, Former Address and Former Fiscal Year if Changed since Last Report



Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period than the registrant was required to file such reports), and (2) has been subject to the filing requirements for the past 90 days.  [X] Yes   [ ]  No

 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). [X ][X] Yes [ ] No

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer or a non-accelerated filer or a smaller reporting company, or an emerging growth company. See definition of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company”” in Rule 12b-2 of the Exchange Act.

Large accelerated filer [ ]   Accelerated filer [ ]   Non-accelerated filer [X]   Smaller reporting company [X]

Emerging growth company[ ]

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act):

[ ] Yes       [X] No

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class                         Trading Symbol(s)       Name of each exchange on which registered

Common Stock, $0.01 par value             CPSH                           NASDAQ Capital Markets

 

 

APPLICABLE ONLY TO CORPORATE ISSUERS:

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.  Number of shares of common stock outstanding as of May 8,July 31, 2020: 13,207,436.13,296,168.

 

PART I  FINANCIAL INFORMATION

 

ITEM 1  FINANCIAL STATEMENTS (Unaudited)

 

CPS TECHNOLOGIES CORP.CORPORATION

Balance Sheets (Unaudited)

 

   March 28,   December 28, 
   2020   2019 
ASSETS       
         
Current assets:        
Cash and cash equivalents $122,255  $133,965 
Accounts receivable-trade, net  5,959,224   4,086,945 
Inventories, net  3,595,338   3,099,824 
Prepaid expenses and other current assets  227,459   147,786 
Total current assets  9,904,276   7,468,520 
Property and equipment:        
Production equipment  9,919,484   9,649,169 
Furniture and office equipment  508,423   508,423 
Leasehold improvements  934,195   934,195 
Total cost  11,362,102   11,091,787 
         
Accumulated depreciation and amortization  (10,224,691)  (10,110,663)
Construction in progress  286,891   255,754 
 Net property and equipment  1,424,302   1,236,878 
Right-of-use lease asset  136,000   171,000 
Deferred taxes, net  147,873   147,873 
 Total Assets $11,612,451  $9,024,271 

 

   June 27,   December 28, 
   2020   2019 
ASSETS    
         
Current assets:        
Cash and cash equivalents $116,612  $133,965 
Accounts receivable-trade, net  4,975,842   4,086,945 
Inventories, net  3,872,868   3,099,824 
Prepaid expenses and other current assets  173,237   147,786 
Total current assets  9,138,559   7,468,520 
Property and equipment:        
Production equipment  10,008,886   9,649,169 
Furniture and office equipment  508,423   508,423 
Leasehold improvements  934,195   934,195 
Total cost  11,451,504   11,091,787 
         
Accumulated depreciation and amortization  (10,357,620)  (10,110,663)
Construction in progress  320,209   255,754 
 Net property and equipment  1,414,093   1,236,878 
Right-of-use lease asset  100,000   171,000 
Deferred taxes, net  147,873   147,873 
 Total assets $10,800,525  $9,024,271 

See accompanying notes to financial statements.

 

(continued)

 

CPS TECHNOLOGIES CORP.CORPORATION

Balance Sheets (Unaudited)

(concluded)

 

  March 28,   December 28,   June 27,   December 28, 
  2020   2019   2020   2019 
LIABILITIES AND STOCKHOLDERS’ EQUITY    
LIABILITIES AND STOCKHOLDERS` EQUITY      
             
Current liabilities:                
Borrowings against line of credit  1,577,506   1,249,588   1,026,765   1,249,588 
Note payable, current portion  45,980   —     37,311   —   
Accounts payable  2,621,862   1,436,417   1,770,160   1,436,417 
Accrued expenses  691,921   815,166   908,994   815,166 
Deferred revenue  381,216   21,110   482,997   21,110 
Lease liability, current portion  136,000   148,000   100,000   148,000 
                
Total current liabilities  5,454,485   3,670,281   4,326,227   3,670,281 
                
Note payable less current portion  159,649   —     159,360   —   
Long term lease liability  —     23,000   —     23,000 
         
Total liabilities  5,614,134   3,693,281   4,485,587   3,693,281 
        
Commitments (note 4)                
Stockholders’ equity:        
Stockholders` equity:        
Common stock, $0.01 par value,                
authorized 20,000,000 shares;                
issued 13,427,492 shares;        
outstanding 13,207,436 shares;        
at March 28, 2020 and December 28, 2019, respectively  134,275   134,275 
issued 13,427,492;        
outstanding 13,207,436;        
at June 27, 2020 and December 28, 2019;  134,275   134,275 
Additional paid-in capital  36,159,874   36,094,201   36,177,264   36,094,201 
Accumulated deficit  (29,778,779)  (30,380,433)  (29,479,548)  (30,380,433)
Less cost of 220,056 common shares repurchased                
at March 28, 2020 and December 28, 2019,  (517,053)  (517,053)
at June 27, 2020 and December 28, 2019  (517,053)  (517,053)
                
Total stockholders’ equity  5,998,317   5,330,990 
Total stockholders` equity  6,314,938   5,330,990 
         
Total liabilities and stockholders’        
Total liabilities and stockholders`        
equity $11,612,451  $9,024,271  $10,800,525  $9,024,271 
         

See accompanying notes to financial statements.

CPS TECHNOLOGIES CORPORATION

Statements of Operations (Unaudited)

   Three Months Ended  Six Months Ended 
   June 27,   June 29,   June 27,   June 29, 
   2020   2019   2020   2019 
Revenues:                
Product sales $5,758,015  $6,366,951  $12,269,586  $11,636,489 
Total revenues  5,758,015   6,366,951   12,269,586   11,636,489 
                 
Cost of product sales  4,574,686   5,191,964   9,536,047   10,302,078 
Gross Margin  1,183,329   1,174,987   2,733,539   1,334,411 
                 
Selling, general, and                
administrative expense  852,773   917,079   1,781,362   1,820,765 
Income (loss) from operations  330,556   257,908   952,176   (486,354)
                 
Interest income (expense), net  (31,325)  (7,310)  (51,291)  (7,261)
Net income (loss) before                
income tax  299,231   250,598   900,885   (493,615)
Income tax provision (benefit)  —     —     —     —   
Net income (loss) $299,231  $250,598  $900,885  $(493,615)
Net income (loss) per                
basic common share $0.02  $0.02  $0.07  $(0.04)
                 
Weighted average number of                
basic common shares                
outstanding  13,207,436   13,206,069   13,207,436   13,206,756 
Net income (loss) per                
diluted common share $0.02  $0.02  $0.07  $(0.04)
Weighted average number of                
diluted common shares                
outstanding  13,259,783   13,260,261   13,253,457   13,206,756 

 

See accompanying notes to financial statements.

 

CPS TECHNOLOGIES CORP.

Statements of Operations (Unaudited)

  Fiscal Quarters Ended 
  March 28,  March 30, 
   2020   2019
       
Revenues:        
Product sales $6,511,571  $5,269,538 
         
Total revenues  6,511,571   5,269,538 
Cost of product sales  4,961,361   5,110,114 
         
Gross Margin  1,550,210   159,424 
Selling, general, and        
administrative expense  928,590   903,686 
  
Income (loss) from operations  621,620   (744,262)
Other income (expense), net  (19,966)  48 
         
Income (loss) before taxes  601,654   (744,214)
Income tax provision (benefit)  —     —   
         
Net income (loss) $601,654  $(744,214)
  
Net income (loss) per        
basic common share $0.05  $(0.06)
         
Weighted average number of        
basic common shares        
outstanding  13,207,436  13,206,069 
         
Net income (loss) per        
diluted common share $0.05  $(0.06)
  
Weighted average number of        
diluted common shares        
outstanding  13,247,131   13,206,069 
  

See accompanying notes to financial statements.

 

CPS TECHNOLOGIES CORPORATION
STATEMENTS OF STOCKHOLDERS’ EQUITY (UNAUDITED)
FOR THE THREE AND SIX MONTHS ENDED MARCH  28,JUNE 27, 2020 AND MARCH 30,JUNE 29, 2019

                         
   Common Stock              
   Number of       Additional           Total 
   shares   Par   paid-in   Accumulated  Stock   stockholders’ 
   issued   Value   capital   deficit   repurchased   equity 
Balance at December 28, 2019  13,427,492  $134,275  $36,094,201   (30,380,433)  (517,053)  5,330,990 
Share-based compensation expense  —     —     65,673   —     —     65,673 
Net income (loss)              601,654   —     601,654 
Balance at March 28, 2020  13,427,492   134,275   36,159,874   (29,778,779)  (517,053)  5,998,317 
                         
Balance at December 29, 2018  13,425,992  $134,260  $35,960,545   (29,742,231)  (517,053)  5,835,521 
Share-based compensation expense  —     —     58,986   —     —     58,986 
Issuance of common stock  1,500   15   2,235   —     —     2,250 
Net income (loss)              (744,214)  —     (744,214)
Balance at March 30, 2019  13,427,492   134,275   36,021,766   (30,486,445)  (517,053)  5,152,543 
             
  Common Stock Additional     Total
  Number of   paid-in Accumulated Stock stockholders'
  shares issued Par Value capital deficit repurchased equity
Balance at March 28, 2020   13,427,492  $134,275  $36,159,874   (29,778,779)  (517,053)  5,998,317 
Share-based compensation expense  —     —     17,390   —     —     17,390 
Issuance of common stock  —     —     —     —     —     —   
Net income              299,231   —     299,231 
Balance at June 27, 2020  13,427,492   134,275   36,177,264   (29,479,548)  (517,053)  6,314,938 

  Common Stock Additional     Total
  Number of   paid-in Accumulated Stock stockholders'
  shares issued Par Value capital deficit repurchased equity
Balance at December 28, 2019  13,427,492  $134,275  $36,094,201   (30,380,433)  (517,053)  5,330,990 
Share-based compensation expense  —     —     83,063   —     —     83,063 
Issuance of common stock  —     —     —     —     —     —   
Net income              900,885   —     900,885 
Balance at June 27, 2020  13,427,492   134,275   36,177,264   (29,479,548)  (517,053)  6,314,938 

             
  Common Stock Additional     Total
  Number of   paid-in Accumulated Stock stockholders'
  shares issued Par Value capital deficit repurchased equity
Balance at March 30, 2019  13,427,492  $134,275  $36,021,766   (30,486,445)  (517,053)  5,152,543 
Share-based compensation expense  —     —     26,411   —     —     26,411 
Issuance of common stock  —     —     —     —     —     —   
Net income              250,599   —     250,599 
Balance at June 29, 2019  13,427,492   134,275   36,048,177   (30,235,846)  (517,053)  5,429,553 

             
  Common Stock Additional     Total
  Number of   paid-in Accumulated Stock stockholders'
  shares issued Par Value capital deficit repurchased equity
Balance at December 29, 2018  13,425,992  $134,260  $35,960,545   (29,742,231)  (517,053)  5,835,521 
Share-based compensation expense  —     —     85,397   —     —     85,397 
Issuance of common stock  1,500   15   2,235   —     —     2,250 
Net (loss)              (493,615)  —     (493,615)
Balance at June 29, 2019  13,427,492   134,275   36,048,177   (30,235,846)  (517,053)  5,429,553 
                         

 See accompanying notes to financial statements.

CPS TECHNOLOGIES CORPORATION

Statements of Cash Flows (Unaudited)

   Six Months Ended   
    June 27,   June 29, 
    2020   2019 
          
Cash flows from operating activities:         
          
Net income (loss)   900,885  $(493,615) 
Adjustments to reconcile net income (loss)         
to cash provided by (used in) operating activities:         
Depreciation and amortization   261,688   278,369 
Share-based compensation   83,063   87,647 
Gain on sale of property and equipment   (5,000)  —   
          
Changes in:         
Accounts receivable-trade   (888,897)  (1,057,298)
Inventories   (773,044)  292,034 
Prepaid expenses and other current assets   (25,451)  (64,304)
Accounts payable   333,743   4,819 
Accrued expenses   93,828   (148,844)
Deferred revenue   461,887   —   
Net cash provided by (used in) operating         
activities   442,702   (1,101,192)
Cash flows from investing activities:         
Purchases of property and equipment   (233,270)  (166,011)
Proceeds from sale of property and equipment   5,000   —   
Net cash used in investing         
activities   (228,270)  (166,011)
Cash flows from financing activities:         
Net borrowings on line of credit   (222,823)  800,000 
Payments on note payable   (8,962)    
Net cash provided by (used in)         
financing activities   (231,785)  800,000 
Net decrease in cash and cash equivalents   (17,353)  (467,203)
         
Cash and cash equivalents at beginning of period   133,965   628,804 
Cash and cash equivalents at end of period  $116,612  $161,601 
         
Supplemental disclosures of cash flows information:         
Cash paid for interest   65,741   —   
         
Supplemental disclosures of non-cash activity:         
Issuance of note payable to finance equipment purchase   208,583   —   

 

See accompanying notes to financial statements.

 

CPS TECHNOLOGIES CORP.

Statements of Cash Flows (Unaudited)

  Fiscal Quarters Ended 
 March 28,   March 30, 
   2020   2019 
         
Cash flows from operating activities:        
Net income (loss) $601,654  $(744,214)
Adjustments to reconcile net income (loss)        
to cash used in operating activities:        
Depreciation and amortization  128,759   139,465 
Share-based compensation  65,673   61,236 
Gain on sale of property and equipment  (5,000)  —   
Changes in:        
Accounts receivable-trade  (1,872,279)  (138,667)
Inventories  (495,514)  115,342 
Prepaid expenses and other current assets  (79,673)  (47,209)
Accounts payable  1,185,445   388,619 
Accrued expenses  (123,245)  (255,980)
Deferred revenue  360,106   —   
Net cash used in operating activities  (234,074)  (481,408)
         
Cash flows from investing activities:        
Purchases of property and equipment  (107,600)  (116,327)
Proceeds from sale of property and equipment  5,000   —   
Net cash used in investing        
activities  (102,600)  (116,327)
Cash flows from financing activities:        
Net borrowings on line of credit  327,918   200,000 
Payments on note payable  (2,954)  —   
Net cash provided by        
financing activities  324,964   200,000 
         
Net decrease in cash and cash equivalents  (11,710)  (397,735)
Cash and cash equivalents at beginning of period  133,965   628,804 
Cash and cash equivalents at end of period $122,255  $231,069 
        
Supplemental disclosures of cash flows information:        
Cash paid for interest $33,216  $—   
        
Supplemental disclosures of non-cash activity:        
Issuance of note payable to finance equipment purchase $208,583  $—   
        

See accompanying notes to financial statements.

CPS TECHNOLOGIES CORP.

CORPORATION
Notes to Financial Statement

Statements
(Unaudited)

(1)  Nature of Business

CPS Technologies Corporation (the “Company” or “CPS”) provides advanced material solutions to the electronics, power generation, automotive and other industries.   The Company’s primary advanced material solution is metal-matrix composites (MMC’s) which are a combination of metal and ceramic.

CPS also assembles housings and packages for hybrid circuits. These housings and packages may include components made of metal-matrix composites or they may include components made of more traditional materials such as aluminum, copper-tungsten, etc.

The Company sells into several end markets including the wireless communications infrastructure market, high-performance microprocessor market, motor controller market, and other microelectronic and structural markets.

 

(2)        Summary of Significant Accounting Policies

As permitted by the rules of the Securities and Exchange Commission applicable to quarterly reports on Form 10-Q, these notes are condensed and do not contain all disclosures required by generally accepted accounting principles.

 

The accompanying financial statements are unaudited. In the opinion of management, the unaudited financial statements of CPS reflect all normal recurring adjustments which are necessary to present fairly the financial position and results of operations for such periods.

 

The Company’s balance sheet at December 28, 2019 has been derived from the audited financial statements at that date, but does not include all of the information and footnotes required by accounting principles generally accepted in the United States of America for complete financial statements.

 

For further information, refer to the financial statements and footnotes thereto included in the Registrant’s Annual Report on Form 10-K for the year ended December 28, 2019 and in CPS’s other SEC reports, which are accessible on the SEC’s website at www.sec.gov and the Company’s website at www.alsic.com.

 

The results of operations for interim periods are not necessarily indicative of the results to be expected for the full year.

 

 

(3)  Net Income (Loss) Per Common and Common Equivalent Share

Basic net income (loss) per common share is calculated by dividing net income (loss) by the weighted average number of common shares outstanding during the period.  Diluted net income (loss)  per common share is calculated by dividing net income (loss) by the sum of the weighted average number of common shares plus additional common shares that would have been outstanding if potential dilutive common shares had been issued for granted stock options and stock purchase rights.  Common stock equivalents are excluded from the diluted calculations when a net loss is incurred as they would be anti-dilutive.

 

The following table presents the calculation of both basic and diluted EPS:

 

  Three Months Ended   June 27,   June 29,   June 27,   June 29, 
  March 28,   March 30,   2020   2019   2020   2019 
  2020   2019         
Basic EPS Computation:     
Numerator:     
Net income (loss) $601,654  $(744,214) $299,231  $250,598  $900,885  $(493,615)
        
Denominator:                        
Weighted average                        
Common shares                        
Outstanding  13,207,436   13,206,069   13,207,436   13,206,069   13,207,436   13,206,756 
        
Basic EPS $0.05  $(0.06) $0.02  $0.02  $0.07  $(0.04)
        
Diluted EPS Computation:                        
Numerator:                        
Net income (loss) $601,654  $(744,214) $299,231  $250,598  $900,885  $(493,615)
        
Denominator:                        
Weighted average                        
Common shares                        
Outstanding  13,207,436   13,206,069   13,207,436   13,206,069   13,207,436   13,206,756 
Dilutive effect of stock options  39,695   —     52,347   54,192   46,021   —   
        
Total Shares  13,247,131   13,206,069   13,259,783   13,260,261   13,253,457   13,206,756 
        
Diluted EPS $0.05  $(0.06) $0.02  $0.02  $0.07  $(0.04)
        

 

 

(4)  Commitments & Contingencies

Commitments

 

Leases

The Company has two real estate leases—one expiring in February 2021 and one with an 11 month duration with options to extend additional years. Since the latter is not reasonably certain that any options will be exercised, it has not been recorded on the balance sheet. CPS also has a few other leases for equipment which are minor in nature and are generally short-term in duration. None of these have been capitalized.

 

The lease expiring in 2021 is included as a right-of-use lease asset and corresponding lease liability on the balance sheet. This asset and liability was recognized on December 30, 2018 based on the present value of remaining lease payments over the remaining lease term using the Company’s incremental borrowing rate at commencement dates. The Company’s lease agreements do not contain any material residual value guarantees or material restrictive covenants.

 

Operating Leases

Lease expense for operating leases is recognized on a straight-line basis over the lease term. Lease expense is includedallocated between Cost of Product Sales and Selling, General and Administrative Expense in rents on the statements of operations and is reported net of lease income. Lease income is not material to the results of operations for the quarter ended March 28, 2020.statement.

 

The following table presents information about the amount, timing and uncertainty of cash flows arising from the Company’s capitalized operating leases as of March 28,June 27, 2020

 

(Dollars in Thousands)  March 28, 2020 
Maturity of capitalized lease liabilities  Lease payments 
2020  117 
2021  26 
Total undiscounted operating lease payments $143 
Less: Imputed interest  (7)
Present value of operating lease liability $136 

(Dollars in Thousands)  June 27, 2020 
Maturity of capitalized lease liabilities  Lease payments 
2020 $76 
2021  26 
Total undiscounted operating lease payments $102 
Less: Imputed interest  (2)
Present value of operating lease liability $100 

 

Additionally, the Company has short-term lease commitments not reflected in the schedule above and not recorded as a right-of-use asset in accordance with the Company’s accounting policy.

Balance Sheet Classification    
Current lease liability $136 
Long-term lease liability  0 
Total operating lease liability $136 
Other Information    
Weighted-average remaining lease term for capitalized operating leases  11 months 
Weighted-average discount rate for capitalized operating leases  6.5%

Balance Sheet Classification    
Current lease liability (recorded in other current liabilities) $100 
Total operating lease liability $100 
Other Information    
Weighted-average remaining lease term for capitalized operating leases  8 months 
Weighted-average discount rate for capitalized operating leases  6.5%
     

 

 

Operating Lease Costs and Cash Flows

Operating lease cost and cash paid was $38$76 thousand during the first quarterhalf year of 2020. This cost is related to its long-term operating lease. All other short-term leases were immaterial.

 

Finance Leases

The company does not have any finance leases.

 

(5)  Share-Based Payments

The Company measures the cost of employee services received in exchange for an award of equity instruments based on the grant date fair value of the award. That cost is recognized over the period during which an employee is required to provide services in exchange for the award, the requisite service period (usually the vesting period). The Company provides an estimate of forfeitures at initial grant date. Reductions in compensation expense associated with the forfeited options are estimated at the date of grant, and this estimated forfeiture rate is adjusted periodically based on actual forfeiture experience. The company uses the Black-Scholes option pricing model to determine the fair value of the stock options granted.

 

During the quarters ended March 28,June 27, 2020 and March 30,June 29, 2019 a total of 59,0000 and 79,00075,000 stock options, respectively, were granted to employees under the Company’s 2020 Equity Incentive Plan and 2009 Stock Incentive Plan, respectively (collectively the “Plan”) and a total of 60,000 and 45,000 stock options, respectively, were granted to outside directors during the quarters ended March 28, 2020 and March 30, 2019

During the quarter ended March 28, 2020 there were no shares issued and during the quarter ended March 30, 2019 there were 1,500 shares issued.  

As of March 28, 2020, there was $198 thousand of total unrecognized compensation cost related to nonvested share-based compensation arrangements granted under the Plan; that cost is expected to be recognized over a weighted average period of 1.47 years.

 

During the quarters ended March 28,June 27, 2020 and March 30,June 29, 2019 there were no shares issued.  

During the three and six months ended June 27, 2020, the Company recognized approximately $66 thousand$17,390 and $59 thousand,$83,063, respectively, as shared-based compensation expense related to previously granted shares under the Plan.

 

During the three and six months ended June 29, 2019, the Company recognized $26,411 and $85,397, respectively, as shared-based compensation expense related to previously granted shares under the Plan.

 

(6)  Inventories

Inventories consist of the following:

   March 28,   December 28, 
   2020   2019 
Raw materials $818,501  $778,409 
Work in process  2,005,211   1,898,916 
Finished goods  1,220,988   871,861 
Gross inventory  4,044,700   3,549,186 
         
Reserve for obsolescence  (449,362)  (449,362)
Inventories, net $3,595,338  $3,099,824 

   June 27,   December 28, 
   2020   2019 
Raw materials $941,757  $778,409 
Work in process  1,997,260   1,898,916 
Finished goods  1,383,213   871,861 
Total inventory  4,322,230   3,549,186 
         
Reserve for obsolescence  (449,362)  (449,362)
Inventories, net $3,872,868  $3,099,824 

 

(7)  Accrued Expenses

Accrued expenses consist of the following:

  March 28,   December 28, 
   2020   2019 
Accrued legal and accounting $28,755  $62,725 
Accrued payroll and related expenses  508,327   518,015 
Accrued other  154,839   234,426 
Total Accrued Expenses $691,921  $815,166 

  June 27,   December 28, 
   2020   2019 
       
Accrued legal and accounting $42,255  $62,725 
Accrued payroll and related expenses  755,148   518,015 
Accrued other  111,591   234,426 
  
  $908,994  $815,166 
  

 

(8)        Line of Credit

In September 2019, the Company entered into revolving line of credit with The Massachusetts Business Development Corporation (BDC) in the amount of $2.5 million.  In May of 2020 this credit line was increased to $3.0 million.  The agreement includes a demand note allowing the Lender to call the loan at any time.  CPS may terminate the agreement without a termination fee after 3 years.  The LOC is secured by the accounts receivable and other assets of the Company and has an interest rate of LIBOR plus 650 basis points. At March 28,June 27, 2020 the Company had $1.578$1.027 million of borrowings under this LOC and its borrowing base at the time would have permitted an additional $922 thousand$1.973 million to have been borrowed. 

 

The line of credit is subject to certain financial covenants, all of which have been met.met or waived.

 

(9)        Note Payable 

In March 2020, the company acquired a Sonoscan ultrasound microscope for a price of $208.$208 thousand.  The full amount was financed through a 5 year note payable with Crest Capital Corporation.  The note is collateralized by the microscope and is being paid in monthly installments of $4 thousand, consisting of principal plus interest at a rate of 6.47%.

 

 

(10)       Income Taxes

A valuation allowance against deferred tax assets is required to be established or maintained when it is "more likely than not" that all or a portion of deferred tax assets will not be realized. In December 2018, the Company established a valuation allowance reserve, as it is judged more likely than not that all or a portion of its deferred tax assets will not be utilized before they expire. This decision was reached after giving greater weight to the Company’s losses in recent years as compared to its forecasts.

 

The Coronavirus Aid, Relief and Economic Security Act (“Act”) became law on March 27, 2020. The Act contains two provisions that provide a tax benefit to the Company. The Act suspends the current 80% limitation on the utilization of net operating losses for taxable years beginning in 2018, 2019 and 2020. The Act also allows net operating losses arising in 2018, 2019 and 2020 to be carried back five years. The Act also accelerates the ability of the Company to recover Federal alternative minimum tax credits.

The Company recorded a reduction of the valuation allowance reserve of $216 thousand during the quarter ended March 28, 2020 to account for the utilization of deferred tax assets to reduce the current tax liability for the quarter ended March 28, 2020. As a result of the utilization of deferred tax assets, the Company did not record aNo provision for income taxes was provided during the quarter and six months ended June 27, 2020, as the Company continues to maintain a full valuation allowance against the majority of its deferred tax assets and no current tax is forecasted for the quarter ended March 28, 2020. year.

 

 

 

ITEM 2       MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

The following discussion and analysis of financial condition and results of operations is based upon and should be read in conjunction with the financial statements of the Company and notes thereto included in this report and the Company’s Annual Report on Form 10-K for the year ended December 28, 2019 and in CPS’s other SEC reports, which are accessible on the SEC’s website at www.sec.gov and the Company’s website at www.alsic.com.

2019.

 

Forward-Looking Statements

This Quarterly Report on Form 10-Q contains forward-looking statements that involve a number of risks and uncertainties. There are a number of factors that could cause the Company’s actual results to differ materially from those forecasted or projected in such forward-looking statements.  This includes the impact of the COVID-19 pandemic, which is discussed in Item 3 of this report. Readers are cautioned not to place undue reliance on these forward-looking statements which speak only as of the date hereof.  The Company undertakes no obligation to publicly release the results of any revisions to these forward-looking statements which may be made to reflect events or changed circumstances after the date hereof or to reflect the occurrence of unanticipated events.

 

Critical Accounting Policies

The critical accounting policies utilized by the Company in preparation of the accompanying financial statements are set forth in Part II, Item 7 of the Company’s Annual Report on Form 10-K for the year ended December 28, 2019, under the heading “Management’s Discussion and Analysis of Financial Condition and Results of Operations”.  There have been no material changes to these policies since December 28, 2019.

 

Overview

Products we provide include baseplates for motor controllers used in high-speed electric trains, subway cars, wind turbines, and hybrid and electric vehicles.  We provide baseplates and housings used in radar, satellite and avionics applications.  We provide lids and heat spreaders used with high performance integrated circuits for use in internet switches and routers.   We provide baseplates and housings used in modules built with Wide Band Gap Semiconductors like SiC and GaN. CPS also assembles housings and packages for hybrid circuits. These housings and packages may include MMC components; they may include components made of more traditional materials such as aluminum, copper-tungsten, etc.

CPS’s products are custom rather than catalog items. They are made to customers’ designs and are used as components in systems built and sold by our customers. At any point in time our product mix will consist of some products with on-going production demand, and some products which are in the prototyping or evaluation stages at our customers. The Company seeks to have a portfolio of products which include products in every stage of the technology adoption lifecycle at our customers. CPS’ growth is dependent upon the level of demand for those products already in production, as well as its success in achieving new "design wins" for future products.

The manufacturing process for MMCs (infusing ceramic materials with molten metals) is complicated and results in varying yields, which poses challenges to profitability for less developed manufacturers.

As a manufacturer of highly technical and custom products, the Company incurs fixed costs needed to support the business, but which do not vary significantly with changes in sales volume. These costs include the fixed costs of applications engineering, tooling design and fabrication, process engineering, etc. Accordingly, particularly given our current size, changes in sales volume generally result in even greater changes in financial performance on a percentage basis as fixed costs are spread over a larger or smaller base. Sales volume is therefore a key financial metric used by management.

The Company believes the underlying demand for metal matrix composites is growing as the electronics and other industries seek higher performance, higher reliability, and reduced costs. CPS believes that the Company is well positioned to offer our solutions to current and new customers as these demands grow.

Our products are manufactured by proprietary processes we have developed including the QuicksetTM Injection Molding Process (‘Quickset Process’) and the QuickCastTM Pressure Infiltration Process (‘QuickCast Process’).

 

CPS was incorporated in Massachusetts in 1984 as Ceramics Process Systems Corporation and reincorporated in Delaware in April 1987 through a merger into a wholly-owned Delaware subsidiary organized for purposes of the reincorporation. In July 1987, CPS completed our initial public offering of 1.5 million shares of our Common Stock. In March 2007, we changed our name from Ceramics Process Systems Corporation to CPS Technologies Corporation.

 

 

Results of Operations for the FirstSecond Fiscal Quarter of 2020 (Q1(Q2 2020) Compared to the FirstSecond Fiscal Quarter of 2019 (Q1(Q2 2019); (all $ in 000’s)000s)

 

Revenues totaled $6,512Total revenue was $5,758 in Q1Q2 2020, a 10% decrease compared with $5,270 generatedtotal revenue of $6,367 in Q1 2019, an increase of 24%. About one third of this increaseQ2 2019. This decrease was due primarily to increased unit volume witha decrease in the balance due to price changessale of baseplates and the shipment of a large infrequent order in Q1Q2 2019. Price increases of 10% offset the overall revenue decrease in Q2 2020 revenue compared with Q1Q2 2019.

 

Gross margin in Q1Q2 2020 totaled $1,550$1,183 or 24%21% of sales.  In Q2 2019, gross margin was $1,175 or 18% of sales.   This increase in margin was primarily due to increased pricing and product mix.

Selling, general and administrative expenses (SG&A) were $853 in Q2 2020, down 7% when compared with SG&A expenses of $917 in Q2 2019.  This reduction in SG&A expense was due, almost equally, to reduced sales commissions on reduced revenue, and reduced travel expenses, as virtually all company travel was shut down due to the Covid-19 pandemic.

In Q2, 2020, the Company incurred interest expense of $32 due to bank borrowings.  This compares with interest expense of $7 in Q2 of 2019.  The increase in interest is due to increased borrowings to finance the growth of accounts receivable and inventory

The Company experienced operating income of $331 compared with an operating income of $258 in the same quarter last year. This increase in operating income is due primarily to the decrease in SG&A expense, discussed above. The net income for Q2 2020 totaled $299 versus $251 in Q2 2019.

Results of Operations for the First Six Months of 2020 Compared to the First Six Months of 2019 (all $ in 000s)

Total revenue was $12,270 in the first half of 2020, a 5% increase compared with total revenue of $11,636 in the first six months of 2019. This increase was due primarily to a 12% increase in pricing during the first half of 2020 compared with the first half of 2019.

Gross margin in the first six months of 2020 totaled $2,734 or 22% of sales.  In the first six months of 2019 gross margin in Q1 2019 of $159totaled $1,334 or 3%11% of sales.  Increases in sales volume as well as a reduction in manufacturing expenses of $202 predominantly account for this change.  As stated above, the salesThis increase was due to the result of increasesincrease in both unit sales volumerevenues, pricing, and price.  The increase of unit sales volume was more than offset by increased efficiencies in manufacturing resulting in the reduction in manufacturing expenses.product mix.

 

Selling, general and administrative (SG&A) expenses totaled $929 in Q1were $1,781 during the first six months of 2020, down 2% compared with SG&A expenses of $904$1,821 in Q1 2019.  Althoughthe first six months of 2019  This reduction is due primarily to reductions in travel due to the Covid-19 pandemic.

During the first half of 2020, the Company has been ableincurred interest expense of $66 due to reduce sales commission rates where appropriate, thisbank borrowings.  This compares with interest expense of $7 incurred during the first half of 2019.  The increase wasin interest is due almost entirely to increased sales commissions as a resultborrowings to finance the growth of increased sales.accounts receivable and inventory

 

TheIn the first six months of 2020 the Company experienced anhad operating profitincome of $622 in Q1 2020$952 compared with an operating loss of $744$486 in Q1 2019 as a result of the improved gross margin.  

same period last year.  The Company is part of the Defense Industrial Base and thus has been open and operating throughout the COVID-19 pandemic.  The COVID-19 pandemic did not affect financial resultsnet income for the quarter ended March 28, 2020.  The Company believes the pandemic will negatively affect financial results, at least modestly, in upcoming quarters. 

Since the outbreakfirst six months of the pandemic, the Company has aggressively implemented CDC guidelines2020 totaled $901 versus a net loss of $494 in the workplace to prevent the spreadfirst six months of COVID-19.  For example, the Company has staggered shifts to eliminate overlap at shift changes, reorganized workstations to ensure social distancing, implemented daily screening of all employees by taking employees’ temperatures, etc.    Where possible, employees are working from home.2019. 

 

Demand from customers remains strong as of today, but this demand may be reduced due to COVID-19 related factors such as government-mandated business closings, inability of our customers to obtain components from other suppliers, etc. 

We are now seeing certain operating costs increasing such as freight costs.   Employee absenteeism has increased due to school closings, employees caring for sick family members, etc. Increased absenteeism is causing labor inefficiencies and increased use of overtime.

Because demand has remained strong, no employees have been furloughed and employee hours have not been reduced.   The Company does not currently need and is not participating in the Payroll Protection Program of the CARES Act.   The Families First Coronavirus Response Act requires the Company to pay employees who are absent due to specific COVID-19 reasons, but allows the Company to recover this cost via a reduction in the Company’s portion of payroll taxes.

All of these factors combine to create a higher degree of uncertainty regarding future financial performance, however, as of today the Company believes the effect of the COVID-19 pandemic on future financial performance will be negative, but modest.

 

Liquidity and Capital Resources (all $ in 000’s000s unless noted)

The Company’s net cash and cash equivalents at March 28,June 27, 2020 totaled ($1,455). (Net$117.  The Company’s net cash, is defined as cash and cash equivalents lesswhich considers the $1,027 of bank borrowings.)borrowings, totaled a negative $910 at the end of the second quarter. This compares to cash and cash equivalents at December 28, 2019 of ($1,116). Payment terms for customers range from payment in advance to 90 days from shipment$134 and are based on factors such as credit worthiness, volumenet cash of business, etc.negative $1,116. The decreaseimprovement in net cash was due primarily to longer terms for our large customers, including the elimination of the prompt pay discount, resulting in an increase in working capital (i.e. receivables and inventory less payables and accruals).gains from operations.

 

Accounts receivable at March 28,June 27, 2020 totaled $5,959$4,976 compared with $4,087 at December 28, 2019.

Days Sales Outstanding (DSO) increased from 67 days at the end of 2019 to 7778 days at the end of Q1Q2 2020.  The increase in DSO was due to higher sales at the end of the quarter compared to the beginning of the quarter, as well as higher sales to one large customer with longer payment terms. The accounts receivable balances at December 28,29, 2019, and March 28,June 27, 2020 were both net of an allowance for doubtful accounts of $10.

 

Inventories totaled $3,595$3,873 at March 28,June 27, 2020 compared with inventory totaling $3,100 at December 28, 2019. This increase was due to increased finished goods awaiting outside plating services for our two largest customers.  The inventory turnover in the most recent four quarters ending Q1Q2 2020 was 6.05.5 times, (based on a 5 point average) compared withdown from 6.2 times averaged during the four quarters of 2019.2019 (based on a 5 point average).

 

 

The Company financed its increase in working capital in Q1Q2 2020 from its profit and increased borrowings of $328 from its line of credit with BDC Capital.profit.  The Company expects it will continue to be able to fund its operations for the remainder of 2020 from existing cash balances and bank borrowings.

 

The Company continues to sell to a limited number of customers and the loss of any one of these customers could cause the Company to require additional external financing. Failure to generate sufficient revenues, raise additional capital or reduce certain discretionary spending could have a material adverse effect on the Company’s ability to achieve its business objectives.

 

Contractual Obligations (all $ in 000’s unless otherwise noted)

 

In September 2019, the Company entered into revolving line of credit (LOC) with Massachusetts Business Development Corporation (BDC) in the amount of $2.5 million.  This agreement replaceswas amended in May 2020 to increase the $1.25 million line of credit with Santander Bank.to $3.0 million.  The agreement includes a demand note allowing the Lender to call the loan at any time.  The Company may terminate the agreement without a termination fee after 3 years.  The LOC is secured by the accounts receivable and other assets of the Company and has an interest rate of LIBOR plus 650 basis points.  At March 28,June 27, 2020 the Company had $1.58$1.03 million of borrowings under this LOC and its borrowing base at the time would have permitted an additional $922 thousand$1.97 million to have been borrowed.  The increased availability has allowed the Company to end its policy of allowing prompt pay discounts to certain customers. This has and should continue to have a positive effect on the Company’s earnings going forward.

 

In March 2020, the company acquired a Sonoscan ultrasound microscope for a price of $208.  The full amount was financed through a 5 year note payable with Crest Capital Corporation.  The note is collateralized by the microscope and is being paid in monthly installments of $4, consisting of principal plus interest at a rate of 6.47%

 

As of March, 28June 27, 2020 the Company had $287$320 of construction in progress and no outstanding commitments to purchase production equipment.

 

The Company has two real estate leases—one expiring in February 2021 and one with an 11 month duration with options to extend additional years. Since the latter is not reasonably certain that any options will be exercised, it has not been recorded on the balance sheet. CPS also has a few other leases for equipment which are minor in nature and are generally short-term in duration. None of these have been capitalized. (Note 4, Leases)

Management believes that a combination of existing cash balances and borrowings, if necessary, will be sufficient to fund our cash requirements for the foreseeable future. However, there is no assurance that we will be able to generate sufficient revenues or reduce certain discretionary spending in the event that planned operational goals are not met such that we will be able to meet our obligations as they become due.

 

 

 

ITEM 3             QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

The Company is not significantly exposed to the impact of interest rate changes or foreign currency fluctuations.  The Company has not used derivative financial instruments.

 

The COVID-19 pandemic presents several risks for the Company.  The Company is part of the Defense Industrial Base and thus has remained open and operating throughout the pandemic.  The primary risks resulting from the pandemic are potential declines in customer demand due to government-mandated business closures and increased operating costs resulting from pandemic-related factors such as increased freight costs and increased employee absenteeism causing labor inefficiencies and increased use of overtime.

 

 The COVID-19 pandemic did not materially affect financial results for the quarter ended March 28,June 27, 2020.  One of our major customers increased inventory above normal levels in Q1 to protect against the risk that their  suppliers, including CPS, would be unable to meet their demands due to the pandemic.  In addition, demand from their customers has declined.   This has resulted in this customer reducing Q2 purchases, and most likely will result in reduced Q3 and Q4 purchases.  The Company believes itthere will negatively affectcontinue to be negative effects on financial results, at least modestly, in upcoming quarters, due to the risks described above.

 

 

 

ITEM 4             CONTROLS AND PROCEDURES

 

(a)        The Company’sCompany`s Chief Executive Officer and Chief Financial Officer have evaluated the effectiveness of the Company’sCompany`s disclosure controls and procedures (as such term is defined in Rules 13a-14(c) and 15d - 14(c)15d-14(c) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) as of the end of the period covered by this Form 10-Q (the “Evaluation Date”).  Based on such evaluation, such officers have concluded that, as of the Evaluation Date,  1) the Company’sCompany`s disclosure controls and procedures are effective to ensure that information required to be disclosed by the Company in reports the Company files under the Securities Exchange Act is recorded, processed, summarized and reported within the time periods specified in the rules and forms of the SEC and 2) the Company’sCompany`s disclosure controls and procedures are effective to ensure that information required to be disclosed in the reports that the Company files or submits under the Exchange Act is accumulated and communicated to our management, including our chief executive officer and chief financial officer, to allow timely decisions regarding required disclosure.

 

(b)        Changes in Internal Controls. There has been no change in our internal control over financial reporting that occurred during our most recent fiscal quarter that has materially affected or is reasonably likely to materially affect our internal control over financial reporting.

PART II OTHER INFORMATION

 

ITEM 1             LEGAL PROCEEDINGS

None.

 

ITEM 1A           RISK FACTORS

There have been no material changes to the risk factors as discussed in our 2019 Form 10-K.10-K

 

ITEM 2             UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS.PROCEEDS

None.

 

ITEM 3             DEFAULTS UPON SENIOR SECURITIES

None.

 

ITEM 4             MINE SAFETY DISCLOSURES

Not applicable.

 

ITEM 5             OTHER INFORMATION

Not applicable.

 

ITEM 6             EXHIBITS AND REPORTS ON FORM 8-K:

(a)Exhibits:

Exhibit 31.1 Certification Of Chief Executive Officer Pursuant To 18 U.S.C. Section 1350, As Adopted Pursuant To Section 302 Of The Sarbanes-Oxley Act Of 2002

 

Exhibit 31.2 Certification Of Chief Financial Officer Pursuant To 18 U.S.C. Section 1350, As Adopted Pursuant To Section 302 Of The Sarbanes-Oxley Act Of 2002

 

Exhibit 32.1 Certification Pursuant To 18 U.S.C. Section 1350, As Adopted Pursuant To Section 906 Of The Sarbanes-Oxley Act Of 2002

 

(b)   Reports on Form 8-K:

On March 5,April 28, 2020 the Company filed a report on Form 8-K relating towhich included final tabulation of votes from the announcementCompany’s Annual Meeting of its financial results for the year ended December 28, 2019 as presented in a press release dated March 4,Shareholders held on April 24, 2020.

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

CPS TECHNOLOGIES CORPORATION


(Registrant)

 

Date:    May 12,August 7, 2020


/s/        Grant C. Bennett


Grant C. Bennett


Chief Executive Officer

 

Date:    May 12,August 7, 2020

/s/        Charles K. Griffith Jr.

Charles K. Griffith Jr.

Chief Financial Officer